NuVasive received regulatory Shonin approval for products supportive of the eXtreme Lateral Interbody Fusion surgical procedure in April 2013 and trained many surgeons in the procedure. The company also reported case volume growth with the Precept, Armada and Co-Roent systems and implants.
More Articles on Spine Devices:
20 Spine Devices Receive FDA 510(k) Clearance in March
LDR Announces Follow-On Public Offering
VertiFlex Submits Final PMA Module for FDA for Superion Interspinous Spacer
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
